Events

Join us on August 27 for a webinar featuring Fredrikson & Byron Immigration attorneys Loan Huynh and Matthew Webster. They will discuss current I-9 enforcement trends, provide I-9 best practices and review the intersection of the Social Security Administration (SSA) “no-match” letters with the I-9 process for employers.

During our Health Law Webinar on August 14, we will explore questions around Medicare Manuals and discuss trends and recent case law dealing with the use of Manuals, FAQs, memos and other program guidance.

Our July 10 Health Law Webinar will explored your rights and obligations when interacting with a variety of governmental and private organizations, including what you should do if government agents visit your facility.

Fredrikson & Byron’s Life Sciences Group is proud to co-present the third annual Investor & Innovator Forum, to be held in Rochester, MN, on Thursday, August 1, 2019.

As a part of the Investor & Innovator Forum on August 1, we hold a Speed Networking session between selected innovative companies and an invite-only list of investors, during which companies will have the opportunity to talk with investors and advisors on a one on one basis for input and insights.

Fredrikson & Byron, P.A. and WIPFLI, LLP are working with MNOppCo to provide a workshop to help legal and accounting professionals navigate opportunity zone client representation.

Our June 2019 Health Law Webinar offered an in-depth analysis of the draft guidance issued by CMS and the practical implications for hospitals struggling to reconfigure and/or plan medical campuses for future growth.

Join our International Group on June 18 for a seminar where we will assess the health of U.S. manufacturing and sourcing in Asia and Latin America and recent country-specific trends.

On May 15, 2019, attorney Kevin Riach presented the Health Law Webinar “Medical Marijuana and Health Care Providers.”

Join Fredrikson’s White Collar & Regulatory Defense Group on May 22 for a discussion on state and federal enforcement priorities with regard to opioids, practical on-the-ground issues cropping up for providers and the future of opioid prescription and regulation.